ArticleScientific reports2026
Development of Nigella sativa essential oil loaded keratin/gelatin cryogel with antimicrobial and antioxidant properties for wound dressing.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The effective management of infected and exudative wounds remains a persistent and critical challenge in clinical practice. Hydrogel-based dressings have emerged as a promising solution for wound healing due to their ability to mimic the native extracellular matrix. In this study, we developed an antimicrobial cryogel wound dressing composed of keratin, gelatin (Kr/Gel), and Nigella sativa essential oil (Kr/Gel@NS-EO). The formulation was engineered via a cryogelation process and strengthened through ionic crosslinking of sodium alginate. The physicochemical characterization using scanning electron microscope, Fourier-transform infrared spectroscopy, and tensile tests confirmed formation of a robust, porous, and fibrous cryogel structure. The material demonstrated optimal wound-dressing properties, such as high porosity, controlled solubility, appropriate moisture content, and favorable water vapor transmission rate that supports a moist environment. Biological evaluations demonstrated multifunctional efficacy. The cryogel showed broad-spectrum antimicrobial effectiveness against Escherichia coli, Staphylococcus aureus, and Candida species (minimum inhibitory concentration: 4–16 µL/mL), significant antibiofilm activity (65–80% inhibition), high biocompatibility (~ 95%), and potent antioxidant capacity (~ 60–100%). In conclusion, Kr/Gel@NS-EO cryogel combines targeted antimicrobial delivery, strong anti-biofilm action, excellent biocompatibility, and controlled release, making it a highly promising candidate for advanced wound management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.